Phase 2 BELIEVE study part B: Efficacy and safety of rilzabrutinib for patients with pemphigus vulgaris

J Eur Acad Dermatol Venereol. 2022 Jun 10. doi: 10.1111/jdv.18318. Online ahead of print.
No abstract available

Keywords: bullous disorders; disease control; pemphigus.

Publication types

  • Letter